Back to URGN
Opaleye Management Inc. → URGN
Opaleye Management Inc. URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
5
Latest value
$58.5M
Q3 2026
Peak value
$58.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $6.3M |
| Q4 2025 | $6.3M |
| Q1 2026 | $25.7M |
| Q2 2026 | $53M |
| Q3 2026 | $58.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $58.5M | 1.44M | — | — |
| Q2 2026 | $53M | 1.44M | — | — |
| Q1 2026 | $25.7M | 1.43M | — | — |
| Q4 2025 | $6.3M | 268.4K | — | — |
| Q4 2025 | $6.3M | 268.4K | — | — |
Other funds holding URGN
$184.6M
$167.2M
$106.4M
$93.6M
$91.7M